Hot Features
Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Revance Therapeutics Inc is a biotechnology company focused on aesthetic and therapeutic offerings, including its neuromodulator product, DaxibotulinumtoxinA for Injection. The company has launched a prestige aesthetics portfolio, which includes the RHA Collection of dermal fillers and the HintMD pl... Revance Therapeutics Inc is a biotechnology company focused on aesthetic and therapeutic offerings, including its neuromodulator product, DaxibotulinumtoxinA for Injection. The company has launched a prestige aesthetics portfolio, which includes the RHA Collection of dermal fillers and the HintMD platform. Its main products include DaxibotulinumtoxinA for Injection and DaxibotulinumtoxinA for Injection Aesthetics. The operating business segments are Product and the Service Segment. The Products segment generates maximum revenue which is engaged in the research and development of aesthetic and therapeutic products. Mehr anzeigen
Revance Therapeutics, Inc. Sued for Securities Law Violations - Contact The Gross Law Firm Before March 4, 2025 to Discuss Your Rights - RVNC PR Newswire NEW YORK, Jan. 16, 2025 NEW YORK, Jan...
Crown Laboratories Extension of Tender Offer to Acquire Revance Therapeutics, Inc. PR Newswire JOHNSON CITY, Tenn., Jan. 13, 2025 JOHNSON CITY, Tenn., Jan. 13, 2025 /PRNewswire/ -- Crown...
Shareholders that lost money on Revance Therapeutics, Inc.(RVNC) Urged to Join Class Action - Contact The Gross Law Firm to Learn More PR Newswire NEW YORK, Jan. 13, 2025 NEW YORK, Jan. 13, 2025...
The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of March 4, 2025 in Revance Lawsuit - RVNC PR Newswire NEW YORK, Jan. 9, 2025 NEW YORK, Jan. 9, 2025 /PRNewswire/ -- The Gross...
Teoxane SA Announces Superior Proposal to Acquire Revance Therapeutics for $3.60 per Share in Cash PR Newswire GENEVA, Jan. 6, 2025 Compelling Cash Proposal Provides 16% Premium Over Revance's...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.37 | 11.1445783133 | 3.32 | 3.69 | 3.23 | 1754105 | 3.26800744 | CS |
| 4 | 0.605 | 19.6110210697 | 3.085 | 3.69 | 3.03 | 2370272 | 3.27932421 | CS |
| 12 | -1.65 | -30.8988764045 | 5.34 | 6.02 | 3.01 | 2922675 | 3.68804927 | CS |
| 26 | -0.39 | -9.55882352941 | 4.08 | 6.65 | 2.755 | 3672436 | 5.16509269 | CS |
| 52 | -1.86 | -33.5135135135 | 5.55 | 7.56 | 2.3 | 2783251 | 4.87755138 | CS |
| 156 | -11.4 | -75.5467196819 | 15.09 | 37.98 | 2.3 | 1808270 | 12.46259497 | CS |
| 260 | -18.8 | -83.5927078702 | 22.49 | 37.98 | 2.3 | 1338551 | 14.41843037 | CS |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
